Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution And Tobramycin Dry Powder For Inhalation In Cystic Fibrosis Patients In Sweden
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.492
https://www.valueinhealthjournal.com/article/S1098-3015(16)31859-9/fulltext
Title :
Cost-Effectiveness Of Levofloxacin Inhalation Solution Vs. Aztreonam Inhalation Solution And Tobramycin Dry Powder For Inhalation In Cystic Fibrosis Patients In Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31859-9&doi=10.1016/j.jval.2016.09.492
First page :
A431
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
461